China SXT Pharmaceuticals, Inc. (SXTC) › Operating IncomeChina SXT Pharmaceuticals, Inc. (SXTC) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: $1.60M2018: $1.63M2019: $1.77M2020: -$1.34M2021: -$2.20M2022: -$5.19M2023: -$5.61M2024: -$2.52M2025: -$2.68M-$2.68M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$2.68M-6.6%2024-$2.52M+55.1%2023-$5.61M-8.1%2022-$5.19M-136.2%2021-$2.20M-63.8%2020-$1.34M-175.8%2019$1.77M+8.4%2018$1.63M+1.9%2017$1.60M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share